News Focus
News Focus
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Wednesday, 05/16/2012 11:21:32 AM

Wednesday, May 16, 2012 11:21:32 AM

Post# of 320
"Biovest retains Ferghana Partners to evaluate strategic transactions (BVTI) 0.39 -0.01 : Co announced that Biovest has retained Ferghana Partners as the Company's strategic transaction advisor to evaluate/implement creative financings and partnering opportunities on a regional or global basis for BiovaxID, its late-stage personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma. "

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today